February 2003

The new building expands on the company’s supply chain solutions for biologics and temperature-sensitive pharmaceuticals.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The company’s mocravimod, a novel oral S1P receptor, is being evaluated for its efficacy as an addition to CAR-T cell therapies.

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

mRNA technologies offer great promise in immunotherapy and non-immunogenic applications.